Cargando…
Focused Ultrasound-Mediated Delivery of Anti-Programmed Cell Death-Ligand 1 Antibody to the Brain of a Porcine Model
Immune checkpoint inhibitor (ICI) therapy has revolutionized cancer treatment by leveraging the body’s immune system to combat cancer cells. However, its effectiveness in brain cancer is hindered by the blood-brain barrier (BBB), impeding the delivery of ICIs to brain tumor cells. This study aimed t...
Autores principales: | Fadera, Siaka, Chukwu, Chinwendu, Stark, Andrew H., Yue, Yimei, Xu, Lu, Chien, Chih-Yen, Yuan, Jinyun, Chen, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610297/ https://www.ncbi.nlm.nih.gov/pubmed/37896238 http://dx.doi.org/10.3390/pharmaceutics15102479 |
Ejemplares similares
-
Incisionless targeted adeno-associated viral vector delivery to the brain by focused ultrasound-mediated intranasal administration
por: Ye, Dezhuang, et al.
Publicado: (2022) -
Focused Ultrasound-Enhanced Delivery of Intranasally Administered Anti-Programmed Cell Death-Ligand 1 Antibody to an Intracranial Murine Glioma Model
por: Ye, Dezhuang, et al.
Publicado: (2021) -
First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound
por: Yuan, Jinyun, et al.
Publicado: (2023) -
Targeted delivery of therapeutic agents to the mouse brain using a stereotactic-guided focused ultrasound device
por: Hu, Zhongtao, et al.
Publicado: (2023) -
Blood-Brain Barrier Opening by Individualized Closed-Loop Feedback Control of Focused Ultrasound
por: Chien, Chih-Yen, et al.
Publicado: (2022)